{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:19:46Z","timestamp":1724458786798},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,23]]},"DOI":"10.7759\/cureus.67625","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:12:22Z","timestamp":1724451142000},"source":"Crossref","is-referenced-by-count":0,"title":["Possible Heterozygous Hypercholesterolemia Among Adults in Basrah, Southern Iraq"],"prefix":"10.7759","author":[{"given":"Elaf A","family":"Khamees","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassar T","family":"Alibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas A","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and treatment of heterozygous familial hypercholesterolemia","volume":"8","author":"McGowan MP","year":"2019","unstructured":"McGowan MP, Hosseini Dehkordi SH, Moriarty PM, Duell PB. Diagnosis and treatment of heterozygous familial hypercholesterolemia. J Am Heart Assoc. 2019, 8:e013225. 10.1161\/JAHA.119.013225","journal-title":"J Am Heart Assoc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard BG","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE, et al.. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013, 34:3478-90a. 10.1093\/eurheartj\/eht273","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"303","year":"1991","unstructured":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ. 1991, 303.893-6. 10.1136\/bmj.303.6807.893","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams RR","year":"1993","unstructured":"Williams RR, Hunt SC, Schumacher MC, et al.. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol. 1993, 72:171-6. 10.1016\/0002-9149(93)90155-6","journal-title":"Am J Cardiol"},{"key":"ref5","article-title":"Familial Hypercholesterolaemia (\u200fFH)\u200f: Report of a Second WHO Consultation","year":"1998","unstructured":"Familial Hypercholesterolaemia (\u200fFH)\u200f. Report of a Second WHO Consultation. World Health Organization, Geneva; 1998."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding SS","year":"2015","unstructured":"Gidding SS, Champagne MA, de Ferranti SD, et al.. The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association. Circulation. 2015, 132:2167-92. 10.1161\/CIR.0000000000000297","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin MA","year":"2004","unstructured":"Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol. 2004, 160:407-20. 10.1093\/aje\/kwh236","journal-title":"Am J Epidemiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14797\/mdcvj.887","article-title":"Past, present, and future of familial hypercholesterolemia management","volume":"17","author":"Rocha VZ","year":"2021","unstructured":"Rocha VZ, Santos RD. Past, present, and future of familial hypercholesterolemia management. Methodist Debakey Cardiovasc J. 2021, 17:28-35. 10.14797\/mdcvj.887","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.03.008","article-title":"Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: a retrospective analysis of a tertiary care database over a 9-year period","volume":"14","author":"Mansour AA","year":"2020","unstructured":"Mansour AA, Alibrahim NT, Alidrisi HA, et al.. Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: a retrospective analysis of a tertiary care database over a 9-year period. Diabetes Metab Syndr. 2020, 14:265-72. 10.1016\/j.dsx.2020.03.008","journal-title":"Diabetes Metab Syndr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251560","article-title":"Familial hypercholesterolemia in the Arabian Gulf Region: clinical results of the Gulf FH Registry","volume":"16","author":"Alhabib KF","year":"2021","unstructured":"Alhabib KF, Al-Rasadi K, Almigbal TH, et al.. Familial hypercholesterolemia in the Arabian Gulf Region: clinical results of the Gulf FH Registry. PLoS One. 2021, 16:e0251560. 10.1371\/journal.pone.0251560","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21608\/ejhm.2023.328645","article-title":"The prevalence of heterozygous familial hypercholesterolemia among premarital couples in Qalubya Governorate in Egypt","volume":"93","author":"Zahid B","year":"2023","unstructured":"Zahid B, Al-Khnifsawi M, Al-Rabbat K, Abdelrahman YH. The prevalence of heterozygous familial hypercholesterolemia among premarital couples in Qalubya Governorate in Egypt. Egypt J Hosp Med. 2023, 93:7690-4. 10.21608\/ejhm.2023.328645","journal-title":"Egypt J Hosp Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9913969","article-title":"Familial hypercholesterolemia (FH) in Iran: findings from the Four-Year FH Registry","volume":"2021","author":"Vaseghi G","year":"2021","unstructured":"Vaseghi G, Taheri M, Heshmat-Ghahdarijani K, et al.. Familial hypercholesterolemia (FH) in Iran: findings from the Four-Year FH Registry. J Lipids. 2021, 2021:9913969. 10.1155\/2021\/9913969","journal-title":"J Lipids"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2023.07.007","article-title":"Prevalence of familial hypercholesterolemia in a country-wide laboratory network in Pakistan: 10-year data from 988, 306 patients","volume":"79","author":"Farhad A","year":"2023","unstructured":"Farhad A, Noorali AA, Tajuddin S, et al.. Prevalence of familial hypercholesterolemia in a country-wide laboratory network in Pakistan: 10-year data from 988, 306 patients. Prog Cardiovasc Dis. 2023, 79:19-27. 10.1016\/j.pcad.2023.07.007","journal-title":"Prog Cardiovasc Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology\/American Heart Association Task\u00a0Force\u00a0on\u00a0Clinical Practice Guidelines","volume":"73","author":"Grundy SM","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al.. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology\/American Heart Association Task\u00a0Force\u00a0on\u00a0Clinical Practice Guidelines. J Am Coll Cardiol. 2019, 73:e285-350. 10.1016\/j.jacc.2018.11.003","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-022-01783-5","article-title":"The clinical importance of differentiating monogenic familial hypercholesterolemia from polygenic hypercholesterolemia","volume":"24","author":"Tandirerung FJ","year":"2022","unstructured":"Tandirerung FJ. The clinical importance of differentiating monogenic familial hypercholesterolemia from polygenic hypercholesterolemia. Curr Cardiol Rep. 2022, 24:1669-77. 10.1007\/s11886-022-01783-5","journal-title":"Curr Cardiol Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2023.12.003","article-title":"Modern approaches to the management of homozygous familial hypercholesterolemia in the Middle East and North Africa","volume":"18","author":"Al-Ashwal A","year":"2024","unstructured":"Al-Ashwal A, Alsagheir A, Al Dubayee M, et al.. Modern approaches to the management of homozygous familial hypercholesterolemia in the Middle East and North Africa. J Clin Lipidol. 2024, 18:e132-41. 10.1016\/j.jacl.2023.12.003","journal-title":"J Clin Lipidol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269742-possible-heterozygous-hypercholesterolemia-among-adults-in-basrah-southern-iraq","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:12:25Z","timestamp":1724451145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269742-possible-heterozygous-hypercholesterolemia-among-adults-in-basrah-southern-iraq"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.67625","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,23]]}}}